A resolution providing for the consideration of the bill (H.R. 3605) to amend the Federal Food, Drug, and Cosmetic Act to authorize an abbreviated new drug application under section 505 of that Act for generic new drugs equivalent to approved new drugs.

Summary

Sets forth the rule for the consideration of H.R. 3605 (generic drug application procedures).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 8 August 1984

   Vote

   Resolution Agreed to in House by Yea-Nay Vote: 304 - 74 (Record Vote No: 360).

   Source: Floor

2. 8 August 1984

   Vote

   Passed/agreed to in House: Resolution Agreed to in House by Yea-Nay Vote: 304 - 74 (Record Vote No: 360).

   Source: Floor

3. 8 August 1984

   Floor

   Called up by House as Privileged Matter.

   Source: Floor

4. 8 August 1984

   Calendars

   Placed on House Calendar No: 249.

   Source: Calendars

5. 8 August 1984

   Reported

   House Committee on Rules Reported an Original Measure. Report No: 98-974.

   Source: Committee

6. 8 August 1984

   Reported

   House Committee on Rules Reported an Original Measure. Report No: 98-974.

   Source: Committee

7. 8 August 1984

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Introduced in House

  summary · EN · 8 August 1984

  Open at official source

Sponsors

• Rep. Derrick, Butler C. [D-SC-3] · D · Sponsor
• · hsru00 · Standing

Related records

• related to ← Drug Price Competition and Patent Term Restoration Act of 1984